《美國股市》納指低收1% 甲骨文績遜重挫14% 蘋果新產品無助股價跌2%
甲骨文(ORCL.US)業績令人失望,其股價周二(12日)暴跌,科技股受壓,納指於三大指數中領跌。納指低收144.28點或1.04%,報13,773.61點。
標普500指數低收25.56點或0.57%,報4,461.9點;道指低收17.73點或0.05%,報34,645.99點。
甲骨文為今日最矚目股份,該股公布第一季收入和收入指引弱於預期後,周二低開12%,全日維持跌幅,收市重挫13.5%。
蘋果(AAPL.US)周二舉行新產品發布會,推出iPhone15等後,蘋果低收約1.7% 。與此同時,Adobe
(ADBE.US)本周公布業績前,股價下跌4%
其他雲競爭對手,包括亞馬遜(AMZN.US)、Google母公司Alphabet(GOOG.US)和微軟(MSFT.US)全部跌幅擴大,收市下跌1.2%至1.8%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.